 Javier Valle
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 33 | 2023 | 456 | 7.970 |
Why?
| | Coronary Artery Disease | 21 | 2023 | 648 | 4.480 |
Why?
| | Coronary Angiography | 15 | 2023 | 311 | 2.640 |
Why?
| | Peripheral Arterial Disease | 7 | 2022 | 378 | 2.120 |
Why?
| | Myocardial Infarction | 15 | 2022 | 967 | 2.070 |
Why?
| | Registries | 16 | 2023 | 1806 | 2.070 |
Why?
| | Angioplasty, Balloon | 5 | 2022 | 88 | 1.920 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2022 | 151 | 1.840 |
Why?
| | ST Elevation Myocardial Infarction | 3 | 2019 | 51 | 1.800 |
Why?
| | Cardiovascular Agents | 3 | 2023 | 126 | 1.760 |
Why?
| | Coronary Artery Bypass | 7 | 2023 | 210 | 1.660 |
Why?
| | Veterans | 10 | 2023 | 1212 | 1.630 |
Why?
| | Veterans Health | 8 | 2020 | 167 | 1.540 |
Why?
| | Vascular Calcification | 7 | 2022 | 123 | 1.480 |
Why?
| | Femoral Artery | 7 | 2022 | 176 | 1.480 |
Why?
| | United States Department of Veterans Affairs | 18 | 2021 | 556 | 1.420 |
Why?
| | Coronary Vessels | 4 | 2020 | 233 | 1.270 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2019 | 395 | 1.230 |
Why?
| | Treatment Outcome | 37 | 2023 | 9319 | 1.230 |
Why?
| | Time-to-Treatment | 2 | 2019 | 148 | 1.220 |
Why?
| | Ischemia | 4 | 2019 | 370 | 1.200 |
Why?
| | Myocardial Revascularization | 5 | 2019 | 72 | 1.150 |
Why?
| | Surgical Procedures, Operative | 6 | 2018 | 214 | 1.140 |
Why?
| | Endovascular Procedures | 4 | 2019 | 273 | 1.140 |
Why?
| | Atherectomy | 7 | 2022 | 33 | 1.130 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 296 | 1.090 |
Why?
| | Preoperative Care | 3 | 2018 | 332 | 1.050 |
Why?
| | Coronary Occlusion | 2 | 2023 | 18 | 1.040 |
Why?
| | Lower Extremity | 3 | 2018 | 334 | 1.040 |
Why?
| | Hospital Mortality | 8 | 2021 | 811 | 1.030 |
Why?
| | United States | 34 | 2021 | 12488 | 0.980 |
Why?
| | Risk Factors | 29 | 2023 | 8958 | 0.960 |
Why?
| | Aged | 38 | 2022 | 19594 | 0.920 |
Why?
| | Angioplasty, Balloon, Coronary | 3 | 2013 | 148 | 0.920 |
Why?
| | Catheterization, Peripheral | 3 | 2021 | 106 | 0.900 |
Why?
| | Hospitals, Veterans | 3 | 2020 | 245 | 0.890 |
Why?
| | Embolic Protection Devices | 2 | 2021 | 10 | 0.890 |
Why?
| | Non-ST Elevated Myocardial Infarction | 2 | 2019 | 16 | 0.840 |
Why?
| | Technology Transfer | 1 | 2021 | 13 | 0.810 |
Why?
| | Radial Artery | 3 | 2021 | 74 | 0.800 |
Why?
| | Time Factors | 23 | 2020 | 6368 | 0.790 |
Why?
| | Coated Materials, Biocompatible | 4 | 2022 | 58 | 0.730 |
Why?
| | Heart Arrest | 3 | 2019 | 291 | 0.710 |
Why?
| | Middle Aged | 33 | 2021 | 27510 | 0.700 |
Why?
| | Humans | 72 | 2023 | 118251 | 0.700 |
Why?
| | Hemorrhage | 5 | 2018 | 606 | 0.700 |
Why?
| | Risk Assessment | 16 | 2022 | 3043 | 0.700 |
Why?
| | Graft Occlusion, Vascular | 1 | 2019 | 35 | 0.680 |
Why?
| | Saphenous Vein | 1 | 2019 | 32 | 0.680 |
Why?
| | Aspirin | 2 | 2019 | 334 | 0.670 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2021 | 189 | 0.670 |
Why?
| | Centralized Hospital Services | 1 | 2018 | 6 | 0.670 |
Why?
| | Male | 45 | 2021 | 57474 | 0.640 |
Why?
| | Healthcare Disparities | 3 | 2018 | 494 | 0.640 |
Why?
| | Fibrinolytic Agents | 2 | 2018 | 233 | 0.640 |
Why?
| | Transportation of Patients | 1 | 2018 | 49 | 0.640 |
Why?
| | Arm | 1 | 2018 | 106 | 0.620 |
Why?
| | Peripheral Vascular Diseases | 1 | 2018 | 98 | 0.620 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.610 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 3 | 0.610 |
Why?
| | Papillary Muscles | 1 | 2017 | 13 | 0.610 |
Why?
| | Endarterectomy, Carotid | 1 | 2017 | 41 | 0.610 |
Why?
| | Tibial Arteries | 1 | 2017 | 13 | 0.590 |
Why?
| | Decision Support Systems, Clinical | 1 | 2019 | 176 | 0.590 |
Why?
| | Carotid Stenosis | 1 | 2017 | 75 | 0.590 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 251 | 0.590 |
Why?
| | Atherectomy, Coronary | 3 | 2022 | 11 | 0.580 |
Why?
| | Renal Artery | 1 | 2017 | 30 | 0.580 |
Why?
| | Renal Artery Obstruction | 1 | 2017 | 32 | 0.580 |
Why?
| | Disease Management | 2 | 2019 | 566 | 0.570 |
Why?
| | Female | 43 | 2021 | 61261 | 0.570 |
Why?
| | Popliteal Artery | 3 | 2022 | 59 | 0.570 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2016 | 84 | 0.540 |
Why?
| | Exercise Test | 1 | 2018 | 552 | 0.530 |
Why?
| | Postoperative Complications | 6 | 2019 | 2230 | 0.530 |
Why?
| | Ticlopidine | 1 | 2015 | 60 | 0.520 |
Why?
| | Stents | 8 | 2020 | 457 | 0.510 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 194 | 0.510 |
Why?
| | Anticoagulants | 2 | 2016 | 555 | 0.510 |
Why?
| | Heart Diseases | 1 | 2018 | 340 | 0.500 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1197 | 0.500 |
Why?
| | Obesity | 2 | 2019 | 2715 | 0.500 |
Why?
| | Contrast Media | 1 | 2017 | 373 | 0.490 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 541 | 0.480 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 301 | 0.480 |
Why?
| | Heart Conduction System | 2 | 2013 | 81 | 0.460 |
Why?
| | Adrenergic Antagonists | 1 | 2013 | 9 | 0.460 |
Why?
| | Mental Health | 1 | 2019 | 566 | 0.460 |
Why?
| | Health Services Accessibility | 1 | 2018 | 776 | 0.420 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 387 | 0.420 |
Why?
| | Cohort Studies | 9 | 2021 | 5078 | 0.410 |
Why?
| | Stroke | 5 | 2022 | 1046 | 0.410 |
Why?
| | Odds Ratio | 7 | 2021 | 993 | 0.410 |
Why?
| | Patient Discharge | 2 | 2016 | 791 | 0.390 |
Why?
| | Mental Disorders | 1 | 2019 | 935 | 0.380 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 939 | 0.370 |
Why?
| | Aged, 80 and over | 11 | 2021 | 6541 | 0.370 |
Why?
| | Vascular Access Devices | 2 | 2020 | 24 | 0.360 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 705 | 0.360 |
Why?
| | Retrospective Studies | 20 | 2022 | 12929 | 0.360 |
Why?
| | Inpatients | 1 | 2013 | 387 | 0.350 |
Why?
| | Aortic Valve | 4 | 2022 | 402 | 0.340 |
Why?
| | Vascular Patency | 4 | 2020 | 98 | 0.300 |
Why?
| | Acute Coronary Syndrome | 2 | 2022 | 257 | 0.300 |
Why?
| | Coronary Stenosis | 2 | 2017 | 39 | 0.300 |
Why?
| | Follow-Up Studies | 7 | 2021 | 4574 | 0.290 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 964 | 0.290 |
Why?
| | Arterial Occlusive Diseases | 2 | 2018 | 74 | 0.280 |
Why?
| | Logistic Models | 5 | 2017 | 1896 | 0.270 |
Why?
| | Heart Failure | 1 | 2018 | 1967 | 0.270 |
Why?
| | Survival Rate | 6 | 2021 | 1716 | 0.260 |
Why?
| | Prognosis | 6 | 2021 | 3424 | 0.260 |
Why?
| | Limb Salvage | 3 | 2019 | 52 | 0.250 |
Why?
| | Comorbidity | 3 | 2019 | 1516 | 0.240 |
Why?
| | Propensity Score | 3 | 2021 | 242 | 0.240 |
Why?
| | Incidence | 7 | 2019 | 2413 | 0.230 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 1857 | 0.220 |
Why?
| | Cardiovascular Diseases | 3 | 2020 | 1795 | 0.210 |
Why?
| | Iliac Artery | 2 | 2020 | 44 | 0.210 |
Why?
| | Practice Guidelines as Topic | 3 | 2019 | 1433 | 0.200 |
Why?
| | Paclitaxel | 1 | 2022 | 193 | 0.200 |
Why?
| | Patient Readmission | 5 | 2019 | 631 | 0.200 |
Why?
| | Punctures | 2 | 2018 | 39 | 0.200 |
Why?
| | Heart Failure, Systolic | 1 | 2021 | 20 | 0.200 |
Why?
| | Troponin | 1 | 2021 | 47 | 0.190 |
Why?
| | Hospitals, Community | 1 | 2020 | 48 | 0.180 |
Why?
| | Lithotripsy | 1 | 2020 | 37 | 0.180 |
Why?
| | Assisted Circulation | 1 | 2019 | 24 | 0.180 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 37 | 0.180 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1469 | 0.180 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 524 | 0.180 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 159 | 0.170 |
Why?
| | Access to Information | 1 | 2019 | 51 | 0.170 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 79 | 0.170 |
Why?
| | Thrombosis | 1 | 2022 | 303 | 0.170 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 53 | 0.170 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2019 | 16 | 0.170 |
Why?
| | Endocrinologists | 1 | 2018 | 12 | 0.170 |
Why?
| | Chronic Disease | 2 | 2023 | 1630 | 0.170 |
Why?
| | Atrioventricular Block | 1 | 2019 | 33 | 0.170 |
Why?
| | Quality Improvement | 2 | 2019 | 962 | 0.170 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 4521 | 0.160 |
Why?
| | Laser Therapy | 1 | 2019 | 104 | 0.160 |
Why?
| | Office Visits | 1 | 2018 | 83 | 0.160 |
Why?
| | Stroke Volume | 1 | 2021 | 513 | 0.160 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2018 | 50 | 0.160 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 458 | 0.160 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2018 | 230 | 0.160 |
Why?
| | Heart Block | 1 | 2018 | 37 | 0.160 |
Why?
| | Carotid Artery, Internal | 1 | 2017 | 34 | 0.150 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 468 | 0.150 |
Why?
| | Thromboembolism | 1 | 2018 | 99 | 0.150 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2017 | 38 | 0.150 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 277 | 0.150 |
Why?
| | Hospitalization | 4 | 2021 | 1778 | 0.150 |
Why?
| | American Heart Association | 1 | 2018 | 270 | 0.150 |
Why?
| | Cardiology | 1 | 2019 | 272 | 0.150 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 62 | 0.150 |
Why?
| | Patient Admission | 1 | 2018 | 177 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 89 | 0.140 |
Why?
| | Decision Making | 2 | 2021 | 806 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 125 | 0.140 |
Why?
| | Angiography | 1 | 2017 | 185 | 0.140 |
Why?
| | Angina, Unstable | 1 | 2016 | 74 | 0.140 |
Why?
| | Patient Care Planning | 1 | 2016 | 142 | 0.140 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 436 | 0.140 |
Why?
| | Electronic Health Records | 2 | 2019 | 809 | 0.130 |
Why?
| | Outpatients | 1 | 2018 | 324 | 0.130 |
Why?
| | Proportional Hazards Models | 2 | 2016 | 1124 | 0.130 |
Why?
| | Cause of Death | 2 | 2019 | 379 | 0.130 |
Why?
| | Prospective Studies | 4 | 2020 | 6443 | 0.130 |
Why?
| | Body Weight | 1 | 2019 | 923 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 964 | 0.120 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 224 | 0.120 |
Why?
| | Acute Disease | 1 | 2017 | 933 | 0.120 |
Why?
| | Echocardiography | 1 | 2016 | 556 | 0.120 |
Why?
| | Pacemaker, Artificial | 2 | 2018 | 105 | 0.110 |
Why?
| | Recovery of Function | 1 | 2017 | 603 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2659 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1656 | 0.110 |
Why?
| | Hospitals | 2 | 2019 | 600 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 990 | 0.110 |
Why?
| | Overweight | 1 | 2016 | 492 | 0.110 |
Why?
| | Michigan | 3 | 2022 | 95 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2491 | 0.100 |
Why?
| | Hypertension | 1 | 2019 | 1199 | 0.090 |
Why?
| | Tunica Intima | 1 | 2010 | 77 | 0.090 |
Why?
| | Carotid Arteries | 1 | 2010 | 184 | 0.090 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 204 | 0.090 |
Why?
| | Body Mass Index | 1 | 2016 | 2074 | 0.080 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 74 | 0.080 |
Why?
| | Mortality | 2 | 2020 | 297 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1196 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1848 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 2159 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 277 | 0.070 |
Why?
| | Defibrillators, Implantable | 1 | 2009 | 299 | 0.070 |
Why?
| | Program Evaluation | 2 | 2017 | 838 | 0.060 |
Why?
| | Prevalence | 2 | 2019 | 2321 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 840 | 0.050 |
Why?
| | Angina Pectoris | 1 | 2020 | 63 | 0.050 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 74 | 0.050 |
Why?
| | Sodium | 1 | 2020 | 200 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4178 | 0.040 |
Why?
| | Health Facilities | 1 | 2019 | 73 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 55 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 131 | 0.040 |
Why?
| | Heart | 1 | 2022 | 630 | 0.040 |
Why?
| | California | 1 | 2019 | 370 | 0.040 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 21 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 307 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1163 | 0.040 |
Why?
| | Recurrence | 1 | 2019 | 971 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 295 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 251 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 533 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2017 | 328 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 340 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 940 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 670 | 0.030 |
Why?
| | Critical Illness | 1 | 2019 | 661 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1338 | 0.030 |
Why?
| | Coronary Disease | 1 | 2016 | 355 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1031 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 374 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2016 | 520 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2855 | 0.030 |
Why?
| | Morbidity | 1 | 2009 | 293 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2009 | 182 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 714 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2009 | 422 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1237 | 0.020 |
Why?
| | Young Adult | 1 | 2018 | 10731 | 0.010 |
Why?
| | Adult | 2 | 2018 | 31324 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 18364 | 0.010 |
Why?
|
|
Valle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|